MLPFX
Price
$11.21
Change
+$0.01 (+0.09%)
Updated
Sep 11 closing price
Net Assets
2.46B
VLPIX
Price
$19.47
Change
-$0.05 (-0.26%)
Updated
Sep 11 closing price
Net Assets
53.12M
Interact to see
Advertisement

MLPFX vs VLPIX

MLPFX vs VLPIX Comparison Chart in %
View a ticker or compare two or three
VS
MLPFX vs. VLPIX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLPFX is a Hold and VLPIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MLPFX has more cash in the bank: 2.46B vs. VLPIX (53.1M). MLPFX pays higher dividends than VLPIX: MLPFX (5.09) vs VLPIX (1.78). MLPFX was incepted earlier than VLPIX: MLPFX (16 years) vs VLPIX (11 years). VLPIX (1.47) and MLPFX (1.45) have similar cost to investors . VLPIX is a more actively managed with annual turnover of: 61.00 vs. MLPFX (14.00). MLPFX has a lower initial minimum investment than VLPIX: MLPFX (1000) vs VLPIX (100000). MLPFX annual gain was more profitable for investors over the last year : 33.03 vs. VLPIX (20.27). MLPFX return over 5 years is better than : 190.95 vs. VLPIX (172.09).
MLPFXVLPIXMLPFX / VLPIX
Total Expense Ratio1.441.15125%
Annual Report Gross Expense Ratio1.451.4799%
Fund Existence16 years11 years-
Gain YTD29.60726.469112%
Front Load6%N/A-
Min. Initial Investment10001000001%
Min. Initial Investment IRAN/AN/A-
Net Assets2.46B53.1M4,640%
Annual Yield % from dividends5.091.78286%
Returns for 1 year33.0320.27163%
Returns for 3 years97.2278.47124%
Returns for 5 years190.95172.09111%
Returns for 10 years169.23179.6094%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ARKK83.580.52
+0.63%
ARK Innovation ETF
BAMO34.820.20
+0.59%
Brookstone Opportunities ETF
AVK12.230.07
+0.58%
Advent Convertible and Income Fund
AVMU43.780.16
+0.37%
Avantis Core Municipal Fixed Inc ETF
THNR25.59-0.41
-1.59%
Amplify Weight Loss Drug & Treatment ETF